Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Retrospective Cohort Study Assessing Remdesivir Effectiveness in Hospitalized COVID-19 Patients With Renal or Hepatic Comorbidities.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 18, 2026
Effectiveness of Remdesivir on All-Cause In-Hospital Mortality in Patients With Chronic Respiratory Comorbidities Who Are Hospitalized With COVID-19 in the United States.
Journal: Journal of medical virology
Published: December 15, 2025
144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.
Journal: Journal of hepatology
Published: November 24, 2025
SARS-CoV-2 resistance analyses from the Phase 3 OAKTREE study of obeldesivir in low-risk nonhospitalized participants with COVID-19.
Journal: Antiviral research
Published: October 14, 2025
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study.
Journal: The Lancet. Infectious diseases
Published: December 20, 2024
Clinical Evaluation of Drug-Drug Interactions with Obeldesivir, an Orally Administered Antiviral Agent.
Journal: Clinical pharmacology and therapeutics
Published: October 30, 2024
Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants.
Journal: Clinical pharmacology and therapeutics
Published: January 31, 2024
Universal symptom monitoring to address presenteeism in healthcare workers.
Journal: American journal of infection control
Published: December 10, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026